Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

29 Sep 2010 07:00

RNS Number : 4602T
Imaginatik PLC
29 September 2010
Β 

ο»Ώ

Β 29 September 2010

Imaginatik plc

("Imaginatik" or the "Company")

Β 

AGM Statement

Contract Win and Management Appointments

Β 

At the Company's Annual General Meeting to be held later today, Matthew Cooper, Executive Chairman of Imaginatik plc (AIM: IMTK.L), a leading provider of idea management software and innovation consultancy, will make the following statement:

Β 

"We continue to make steady progress towards achieving our strategic goals. A new management team is now largely in place and has been further strengthened by the two recent appointments referred to below.

Β 

"As stated in the announcement dated 18 August 2010, we believe that it will take time to rebuild the Company's sales pipeline. However, the recently announced contract wins and a further win with the U.S. Government announced today are evidence of a growing momentum.

Β 

"While the re-organisation of the business earlier this year will inevitably have an impact on results for the first half of the year, we expect to see a return to more normal levels of sales in the second half.

Β 

"The calibre of people joining our team and the high profile customers with whom we continue to work give us confidence in the future of Imaginatik."

Β 

The Company also announces today a contract win and two senior management team appointments.

Β 

Contract to supply innovation solutions to the United States Government, General Services Administration

Β 

Imaginatik has been selected as a strategic innovation solutions provider by QinetiQ North America, Inc. in support of the United States Government, General Services Administration (the "GSA"). QinetiQ North America, one of the world's leading defence technology and security companies, has issued Imaginatik a six month Subcontract Agreement worth over $400,000, with one six month option period, to assist in enabling Business Transformation and Collaboration at the GSA. Under this Agreement, Imaginatik will use its Idea Central Collaboration Platform to assist GSA in identifying innovation strategies to enhance business practices. It includes licenses for GSA's 15,000 associates, facilitation and programme management support, and various training initiatives to foster collaboration at GSA.

Β 

Senior Appointments

Β 

Imaginatik is also pleased to announce it has made two recent senior appointments to strengthen the Company's sales and product development capabilities. Neither appointment is a Board position.

Β 

Kevin Grygiel has been appointed Global Vice-President of Sales. Based in Boston, Kevin will lead the sales organisation, reporting to Luis Solis the Vice-President of Business Development. Kevin has more than 20 years in software sales, with the last eight years at SiteScape Inc. a collaboration and social media software business. This appointment affirms the Company's commitment to bringing in high calibre sales executives with relevant expertise capable of growing the business.

Β 

Robin Spencer, previously Senior Research Fellow, Idea Management & Innovation at Pfizer Inc., has joined Imaginatik as Director of Research. Rob will work within the Product Development team in building out all future product enhancements and will continue Imaginatik's tradition of leading edge empirical research within our field of innovation and collaborative problem solving.

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 020 7917 2975

Matthew Cooper, Chairman / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

Β 

Β 

About Imaginatik

Β 

Imaginatik provides Innovation and idea management solutions to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

Β 

Imaginatik provides customers with strategic consulting, the award-winning Idea Central technology solution and an experienced, results-oriented innovation consulting team.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte.

Β 

For more information visit www.imaginatik.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMDMGZLKRGGGZM
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.